146 related articles for article (PubMed ID: 14586252)
21. [Treatment of non-alcoholic steatohepatitis].
Fehér J; Hagymási K
Orv Hetil; 2004 Mar; 145(12):631-4. PubMed ID: 15119118
[No Abstract] [Full Text] [Related]
22. Evaluation and management of non-alcoholic steatohepatitis.
Reid BM; Sanyal AJ
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1117-22. PubMed ID: 15489568
[TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic fatty liver disease of obesity.
Sachdev MS; Riely CA; Madan AK
Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
[TBL] [Abstract][Full Text] [Related]
24. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.
Bullock RE; Zaitoun AM; Aithal GP; Ryder SD; Beckingham IJ; Lobo DN
J Hepatol; 2004 Oct; 41(4):685-6. PubMed ID: 15464253
[No Abstract] [Full Text] [Related]
25. [Non-alcoholic steatohepatitis. Clinico-analytical study of 40 cases].
Moreno Sánchez D; Solís Herruzo JA; Vargas Castrillón J; Colina Ruiz-Delgado F; Lizasoain Hernández M
Med Clin (Barc); 1987 Jun; 89(5):188-93. PubMed ID: 3626676
[No Abstract] [Full Text] [Related]
26. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
27. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
Ahmed MH
Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367
[No Abstract] [Full Text] [Related]
28. [Pathological and clinical analysis of nonalcoholic steatohepatitis].
Pan HY; Ye RX; Shi JP; Guo XF
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):384. PubMed ID: 12837234
[No Abstract] [Full Text] [Related]
29. Pediatric nonalcoholic fatty liver disease in 2009.
Alisi A; Manco M; Vania A; Nobili V
J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
[No Abstract] [Full Text] [Related]
30. Non-alcoholic steatohepatitis.
Luyckx FH; Scheen AJ; Lefèbvre PJ
Lancet; 1999 Oct; 354(9186):1298-9. PubMed ID: 10520658
[No Abstract] [Full Text] [Related]
31. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
32. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
33. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
[TBL] [Abstract][Full Text] [Related]
34. [Non-alcoholic steatohepatitis].
Vecchione R; Giannatiempo R; Fiorentino F; Terracciano L
Pathologica; 2003 Oct; 95(5):252. PubMed ID: 14989001
[No Abstract] [Full Text] [Related]
35. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic steatohepatitis in children and adolescents.
Manton ND; Lipsett J; Moore DJ; Davidson GP; Bourne AJ; Couper RT
Med J Aust; 2000 Nov; 173(9):476-9. PubMed ID: 11149304
[TBL] [Abstract][Full Text] [Related]
37. [Nonalcoholic steatohepatitis--current treatment options].
Gutkowski K; Gutkowska D; Partyka M
Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
[TBL] [Abstract][Full Text] [Related]
38. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
Pagadala M; Zein CO; McCullough AJ
Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of non-alcoholic steatohepatitis: human data.
Edmison J; McCullough AJ
Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
